期刊
JMIR PUBLIC HEALTH AND SURVEILLANCE
卷 7, 期 1, 页码 189-200出版社
JMIR PUBLICATIONS, INC
DOI: 10.2196/20236
关键词
telemedicine; telehealth; herbal medicine; Korean medicine; COVID-19; Korea; pandemic; guideline; infectious disease
资金
- Association of Korean Medicine
- Korea Institute of Oriental Medicine [KSN2021210, KSN2021220]
- COVID-19 telemedicine center of Korean Medicine
- National Research Council of Science & Technology (NST), Republic of Korea [KSN2021220] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
The study describes the results of the Korean Medicine (KM) telemedicine center in treating COVID-19 patients with herbal medicine. The center has provided medical service to 10.8% of all COVID-19 patients in South Korea and continues to operate. The use of herbal medicine has shown significant improvement in COVID-19 symptoms.
Background: COVID-19 was first reported in Wuhan, China, in December 2019, and it has since spread worldwide. The Association of Korean Medicine (AKOM) established the COVID-19 telemedicine center of Korean medicine (KM telemedicine center) in Daegu and Seoul. Objective: The aim of this study was to describe the results of the KM telemedicine center and the clinical possibility of using herbal medicines for COVID-19. Methods: All procedures were conducted by voice call following standardized guidelines. The students in the reception group obtained informed consent from participants and they collected basic information. Subsequently, Korean Medicine doctors assessed COVID-19-related symptoms and prescribed the appropriate herbal medicine according to the KM telemedicine guidelines. The data of patients who completed the program by June 30, 2020, were analyzed. Results: From March 9 to June 30, 2020, 2324 patients participated in and completed the KM telemedicine program. Kyung-Ok-Ko (n=2285) was the most prescribed herbal medicine, and Qingfei Paidu decoction (I and II, n=2053) was the second most prescribed. All COVID-19-related symptoms (headache, chills, sputum, dry cough, sore throat, fatigue, muscle pain, rhinorrhea, nasal congestion, dyspnea, chest tightness, diarrhea, and loss of appetite) improved after treatment (P<.001). Conclusions: The KM telemedicine center has provided medical service to 10.8% of all patients with COVID-19 in South Korea (as of June 30, 2020), and it is still in operation. We hope that this study will help to establish a better health care system to overcome COVID-19.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据